Overview

Also known as:

Congenital disorder of glycosylation due to PIGM deficiency PIGM-CDG

Treatments

No FDA-approved treatments are currently listed for Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency community →

Specialists

View all specialists →

No specialists are currently listed for Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiencyForum →

No community posts yet. Be the first to share your experience with Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency.

Start the conversation →

Latest news about Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency

No recent news articles for Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.